… As commonly happens, emerging data have generated just as many questions as they have
answered. The aim of the present review is to summarize the current knowledge about MPE …

… Management of malignant pleural effusions: questions that need answers. Curr Opin
Pulm … treatment of malignant pleural effusion in patients with non-small cell lung cancer (Review). …

… lung bases, then a pleural effusion of cardiac origin is highly likely, and we are thus probably
dealing with a transudate rather than … known to have lung cancer with a pleural effusion, but …

… than 50 days in the urological cancer, sarcoma, and melanoma groups, compared with 339
days for those patients with mesothelioma. The lung cancer … definitively answer the question …

… Answers to these important questions are needed to move the field forward. This article
collates … Dr RT is a consultant respiratory physician leading the lung cancer and interventional …

… Lung cancer typically spreads via a hematogenous route to the visceral pleura and then seeds
the nearby parietal pleura … sensitive than pleural fluid cytology for most types of tumor [48]. …

… thoracentesis, intrapleural fibrinolytics and surgery but many questions remain to be
answered. … , mesothelioma, lung cancer and haematological malignancies.54-58 One-third of …

… Patients with an actionable mutation with non-small cell lung cancer and malignant pleural
effusion have been associated with a similar risk of recurrence when compared to those …

… biopsy to detect cancer cells. For patients with clear primary tumors and … for the effusion
itself (7–10). Once the amount of pleural effusion increases or if substantial pleural effusion is …

… increased in lung squamous cell carcinoma [Citation39]. … diagnosis of lung cancer-related
malignant pleural effusion are … diagnosis of lung cancer-related malignant pleural effusion. The …